Tong J. Prothrombotic fibrin clot phenotype in obstetric antiphospholipid syndrome: clinical implications and unanswered questions. Pol Arch Intern Med. 2026; 136: 17236. doi:10.20452/pamw.17236 ...

Fibrin clot formation represents the culminating step in the coagulation cascade, wherein soluble fibrinogen is converted into insoluble fibrin, creating a structural network essential for haemostasis ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus, causes coronavirus disease 2019 (COVID-19), which is a multisystem disease affecting the respiratory tract. Data ...

A group of researchers from the United States discovered that the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can induce the formation of highly inflammatory ...

One of the hallmarks of COVID-19, the disease caused by SARS-CoV-2, is a multi-organ system process characterized by the formation of blood clots in small vessels. What was most puzzling in the early ...

The top panel, designed with BioRender.com, illustrates the process of clot formation and lysis, beginning with platelet aggregation and activation of the coagulation cascade, followed by the ...

“Compared to normal plasma, hemophilia plasma delays clot formation and reduces stability in tissue factor-triggered assays, and products that enhance hemostasis improve these characteristics.” All ...

Researchers analyze bone marrow-derived and peripheral blood-derived fibrin clots showing that the former contains more growth factors. They then show that bone marrow-derived fibrin clots can be used ...

The blood protein fibrin plays a key role in stopping bleeding, but in certain circumstance it can also contribute to disease. Therein lies the challenge for developing a fibrin-targeting drug.

Researchers at Stanford have developed a new technology for removing blood clots that is more than twice as effective as current techniques. It could significantly improve success rates in treating ...

Piróg M, Ząbczyk M, Natorska J, et al. Prothrombotic fibrin clot phenotype in obstetric antiphospholipid syndrome: clinical implications and unanswered questions. Authors’ reply. Pol Arch Intern Med.